Cover Image

Epidermolysis Bullosa Acquisita due to Epitope Spreading in a Patient With Recurrent Bullous Pemphigoid

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Athina‐Ioanna Daponte, Anastasia Tsitlakidou, Athanasia Tsaousi, Parthena Meltzanidou, Aikaterini Kyriakou, Anastasia Giannakou, Elizabeth Lazaridou, Aikaterini Patsatsi
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	International Journal of Dermatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of Serum Levels of Total‐IgE and Specific antiBP180 IgE Autoantibodies With Disease Activity and Severity in Patients With Bullous Pemphigoid
by: Aikaterini Kyriakou, et al.
Published: (2025)

Bullous pemphigoid: Investigating the risk of losing functional autonomy in everyday life
by: Aikaterini Patsatsi, et al.
Published: (2025)

Epidermolysis Bullosa Acquisita With Extensive Esophageal Erosions
by: Erina Taniguchi, et al.
Published: (2025)

Lewis blood group antigens and ABH secretor status in patients with pemphigus
by: Foteini Lamprou, et al.
Published: (2024)

Epidermolysis Bullosa and Psychodermatology
by: Csanád Szabó
Published: (2025)

Multidisciplinary Management of Epidermolysis Bullosa
by: James A. Feinstein, et al.
Published: (2026)

Epidermolysis Bullosa: Fragile Skin, Fragile Hope
by: Pragya Kafley
Published: (2025)

Dapagliflozin‐Associated Bullous Pemphigoid
by: Xun Feng, et al.
Published: (2025)

Involvement of Ferroptosis in Bullous Pemphigoid Pathogenesis
by: Shiling Geng, et al.
Published: (2025)

Bibliometric Analysis of the 50 Most Cited Publications in Epidermolysis Bullosa
by: Evelyn F. Fagan, et al.
Published: (2025)

Immune Checkpoint Inhibitor–Associated Autoimmune Bullous Diseases: Beyond Bullous Pemphigoid
by: Ioannis‐Alexios Koumprentziotis, et al.
Published: (2026)

Lichenoid Drug Eruption due to Telmisartan–Hydrochlorothiazide Combination Progressing to Bullous Pemphigoid: A Case Report
by: Satoko Minakawa, et al.
Published: (2025)

Reassessing Ferroptosis in Bullous Pemphigoid: Methodological and Translational Considerations
by: Yang Li
Published: (2025)

Novel Clinical Observations Indicative of Epidermolysis Bullosa Simplex Associated With KLHL24
by: Madison Anzelc, et al.
Published: (2025)

Treatment Landscape for Epidermolysis Bullosa Simplex: A Review of Established and Emerging Therapies
by: Grace B. Hanrahan, et al.
Published: (2026)

Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa—Impact of Oleogel‐ S10
by: Anna L. Bruckner, et al.
Published: (2025)

Use of Lebrikizumab in Treatment‐Refractory Bullous Pemphigoid: Two Reports
by: Christoph Zeyen, et al.
Published: (2026)

El Disfrute de la Experiencia Audiovisual por Personas Sordas y con Diversidad Auditiva: La Representación Visual de los Efectos Sonoros
by: Aikaterini Tsaousi
Published: (2018)

Management of Bullous Pemphigoid in Special Populations: A Narrative Review of the Literature
by: Giulia Gasparini, et al.
Published: (2025)

Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity
by: Yutong Ran, et al.
Published: (2025)

Dual Immune‐Related Toxicities: Secukinumab‐Induced Bullous Pemphigoid Following ICI ‐Associated Psoriasis in a Cancer Patient
by: Ioanna A. Paschou, et al.
Published: (2025)

Assessment of Growth Hormone and Insulin‐Like Growth Factor 1 in Children With Epidermolysis Bullosa Dystrophica
by: Mohammad El Darouti, et al.
Published: (2025)

Long‐Term Efficacy and Safety of Oleogel‐ S10 (Birch Triterpenes) for Pediatric Patients With Epidermolysis Bullosa
by: Eli Sprecher, et al.
Published: (2026)

A Case of Bullous Pemphigoid in a Patient With Systemic Sarcoidosis and Relapsing Polychondritis
by: Takehiro Nakamura, et al.
Published: (2025)

Immune Checkpoint Inhibitor‐Related Bullous Pemphigoid: Distinct Clinical and Immunological Profiles
by: Min Zou, et al.
Published: (2026)

Pediatric Bullous Pemphigoid Treated With Dupilumab: A Case Report With Good Response
by: Aldana Belén Almassio, et al.
Published: (2025)

Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study
by: Gianluca Avallone, et al.
Published: (2025)

A Case of Bullous Pemphigoid Coexisted With Psoriasis Vulgaris Successfully Treated by Apremilast
by: Haruna Kumagai, et al.
Published: (2026)

BP230 ‐Type Bullous Pemphigoid is a Rare Subset of Bullous Pemphigoid Associated With a Favorable Prognosis: A Retrospective Analysis From a Tertiary Referral Center
by: Roberto Maglie, et al.
Published: (2025)

The Clinical Efficacy and Safety of Dupilumab Monotherapy in Dystrophic Epidermolysis Bullosa: A Retrospective Real‐World Study
by: Jian-Bo Wang, et al.
Published: (2026)

Tissue Eosinophil Counts: A Promising Marker for Optimizing Omalizumab Treatment in Bullous Pemphigoid
by: Gülfem Akin, et al.
Published: (2025)

Real‐World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens
by: Kateryna Karpoff, et al.
Published: (2026)

Successful Use of Upadacitinib in Treating a Child With Epidermolysis Bullosa Pruriginosa: A Case Report and Literature Review
by: Xumei Wu, et al.
Published: (2025)

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real‐world data from a multicentre study
by: Vasiliki Nikolaou, et al.
Published: (2024)

Junctional Epidermolysis Bullosa With Pyloric Atresia Complicated by Esophageal Atresia and Nephrotic Syndrome: A Case Report and Review of the Literature
by: Kennedy Sabharwal, et al.
Published: (2025)

An Acid‐Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds
by: Xiaolong A. Zhou, et al.
Published: (2025)

Revisiting the Pathology of Bullous Pemphigoid: Basal Cell Necrosis as a Diagnostic Clue and Its Pathogenic Role
by: Hsuan Chen, et al.
Published: (2025)

The Secretome of Bullous Pemphigoid IgG ‐Treated Keratinocytes Induces a Pro‐Inflammatory Eosinophil Response
by: Adrian P. Mansini, et al.
Published: (2026)

Differential Tumour Necrosis Factor‐Like Weak Inducer of Apoptosis ( TWEAK ) Associations in Pemphigus and Bullous Pemphigoid
by: Shiran Kang, et al.
Published: (2026)

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development
by: Belen de Nicolas‐Ruanes, et al.
Published: (2025)